Monthly Archives: January 2021

Make your MLB plans for the 2021 season with Yahoo Fantasy Baseball.

Yahoo Fantasy Baseball is officially LIVE for the 2021 season, and were proud to once again be the official Fantasy Commissioner Game of MLB.com.

We know many of you have been waiting to make your Fantasy Baseball plans for the upcoming season. The wait is over sign up today!

As for the 2021 version of our game, everything you love is back. New to fantasy? Need a refresher on how to play? We have you covered.

Yahoo Fantasy will also help you get ready to draft with advice from some of the best analysts in the business, including Andy Behrens, Dalton Del Don, and Scott Pianowski.

[Batter up: Join or create a Yahoo Fantasy Baseball league for free today]

Our experts already have their early draft rankings out. In the coming days and weeks, well follow up with position primers, sleepers, busts, breakout candidates and so much more. Let our analysts do the work so you dont have to sweat getting ready for your draft.

But the draft itself is just the beginning of Fantasy Baseball. Well keep you up to speed all season long with waiver wire advice, emerging trends, prospects to stash, and our ground-breaking Fearless Forecast series with hundreds of player predictive videos each week so you can stay ahead of the competition.

And be sure to follow us on Twitter and Facebook for ongoing fantasy tips for both season-long and Daily Fantasy.

Coming off the unprecedented 2020 season, which featured a 60-game schedule, we wanted to address a couple of pressing questions ...

We've adjusted scoring for points-only and head-to-head points leagues to have better balance between fantasy value for pitchers and hitters. Since these are private leagues, the settings can always be adjusted by any commissioner.

Story continues

Now go sign up for Yahoo Fantasy Baseball and start prepping for the 2021 season. Good luck!

View post:

Yahoo Fantasy Baseball is open: Sign up to play for the 2021 season - Yahoo Sports

TipRanks

We are entering a new paradigm for the oil and gas industry, one far removed from the Trump Presidencys pro-drilling policies. The Biden Admin is likely to cut back on oil and gas production in the US, in favor of promoting renewable energy sources and carbon pollution reduction. In the short run, his policies are likely to push oil and gas prices up and that may turn out to help the hydrocarbon sector, at least at the bottom line, over the coming year. But for the oil companies, the lessons of 2020 appear in the balance sheets. The massive spike down in prices last May, followed by a quick recovery, only to finish the year at roughly the same price as it began all of this has the producers looking to cut back on spending, consolidate or reduce debt, and maintain free cash flow. In the words of Raymond James oil industry analyst John Freeman: [We] enter 4Q20 earnings and 2021 capital budget season with WTI trading, ironically, in essentially the same low $50s range as we did this time last year. While crude is largely in the same spot, the industry has definitely undergone a strategic shift with balance sheet health and returning capital to shareholders by far the highest priorities. In addition to noting the general trend of the industry after a difficult year, Freeman has also been updating his stance on individual oil and gas stocks. Two in particular have gotten Freemans attention. He sees at least 50% upside potential for each of them. We ran the two through TipRanks' database to see what other Wall Street's analysts have to say about them. Apache Corporation (APA) With headquarters in Houston, Texas, Apache is an important operator in the North American oil industry. The companys US hydrocarbon exploration and production activities are located in the Permian Basin, along the Gulf Coast, and in the Gulf Mexico. Apache also has operations in the UK (in the North Sea), in Egypt (in the Western Desert), and in Suriname (offshore). The companys Permian holdings include 665.8 million barrels of oil equivalent, 66% of its proven reserves. The company beat the quarterly revenue expectations in the third quarter, with $1.12 billion at the top line. Since reporting the Q3 revenue, Apaches stock has gained 71%. The company reported 445,000 barrels of oil equivalent per day in Q3 production. Covering the stock for Raymond James, analyst John Freeman writes: We continue to like Apache's diversified portfolio of U.S. onshore and international assets (Egypt, the North Sea, and Suriname), and given Apache's considerable commodity exposure (only hedged Waha basis in 2021), the company is ideally situated to capitalize on our projected resurgence in commodity prices in the 2021/2022 timeframe. Adding to this, the operator has an extremely robust FCF profile [and] proven commitment to capital discipline In line with these comments, the analyst gives APA a Strong Buy rating and a $24 price target that implies a 60% upside potential over the coming 12 months. (To watch Freemans track record, click here) Freeman leads the Bulls on Apache. The stock has a Moderate Buy from the analyst consensus, based on 12 reviews that include 6 Buys, 5 Holds, and 1 Sell. The shares are selling for $14.94, and their $19.30 average price target suggests room for 29% upside growth this year. (See APA stock analysis on TipRanks) Diamondback Energy (FANG) Also based in Texas, Diamondback Energy is another player in the Permian Basin energy boom. The company boasts an $8.9 billion market cap and saw revenues hit $720 million in the third quarter of 2020. Production in the quarter averaged 287.8 thousand barrels of oil equivalent per day. Diamondbacks reserves total more than 1.12 billion barrels of oil equivalent, of which 63% are oil and 37% are natural gas and related liquids. Diamondback is expanding its operations through M&A activity. In December of last year, the company announced that it will be acquiring QEP Resources, a natural gas driller in the Midland Basin of the Permian formation along with operations in North Dakotas Williston formation. The acquisition is an all-stock deal, worth an estimated $2.2 billion. QEP brings 49,000 acres in the Midland for potential development, an average production of 48,300 thousand BOE per day, and 48 drilled but uncompleted wells. These assets are accretive to Diamondbacks portfolio. In a related piece of news, Diamondback has announced that it will also be acquiring Guidon, another rival Texas oil producer. Guidon brings additional Permian assets to Diamondback, and the acquisition is significant, valued at $862 million in both cash and stock. Casting his eye on Diamondback, Freeman sees the company in a strong position to meet the challenges of both the energy environment and the Biden Administrations regulatory policies. Going forward with the addition of QEP and Guidon acreage we anticipate the Midland accounts for ~75% of pro forma activity. Note that even after the QEP/Guidon acquisitions, FANG still has no federal acreage exposure - a significant positive given regulatory uncertainty will likely persist following the expiration of the 60-day leasing moratorium We believe FANG offers considerable upside potential over the long-term and are confident in the company's ability to weather near-term commodity uncertainties, Freeman opined. Unsurprisingly, Freeman rates FANG as a Strong Buy, along with a $91 price target. This figure indicates confidence in ~51% growth over the next 12 months. (To watch Freemans track record, click here) Theres broad agreement on Wall Street with Freemans position here. FANG stock holds a Strong Buy rating from the analyst consensus, based on 13 recent Buy reviews against just 3 Holds. The average price target is $67.37, which implies ~12% upside from the current trading price of $67.37. (See FANG stock analysis on TipRanks) To find good ideas for oil stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Read more:

GameStop mania has gotten inside the head of Wall Street - Yahoo Finance

Stocks dipped Friday morning, reversing course after a recovery rally on Thursday.

The Dow fell more than 150 points, or about 0.6%, shortly after the opening bell. The index had closed higher by 1%, or 300 points, a day earlier. Still, each of the Dow, S&P 500 and Nasdaq were on track to post weekly losses after dipping earlier in the week.

Shares of some of the heavily shorted stocks that had become popular picks among members of Reddits r/wallstreetbets forum surged anew after sliding during the regular session and giving back steep gains from earlier this week. GameStop (GME) shares rocketed higher after nearly halving on Thursday. Shares of AMC (AMC) also soared Friday after sliding on Thursday, as did shares of BlackBerry (BB), Express (EXPR), Bed Bath & Beyond (BBBY) and Nokia (NOK).

Over the course of this week, trading in these and other heavily shorted names generated historic trading volumes in equity markets, surpassing even the volume of trades taking place at the most volatile points of the pandemic in 2020. More than 23.6 billion shares of U.S.-traded stocks were exchanged on Wednesday this week, according to Bloomberg data, marking the most ever in records spanning more than a decade.

The Securities and Exchange Commission (SEC) said Friday it was closely monitoring and evaluating the extreme price volatility of certain stocks trading prices over the past several days, according to a statement. A day earlier, online brokerages including Robinhood, Webull Financial and E-Trade Financial blocked buying of many of these volatile shares, drawing the ire of users, criticism from lawmakers and a class action lawsuit against Robinhood for the trading restrictions.

Elsewhere, recent reports on U.S. economic activity came in better than expected, pointing to a tentative improvement in the economic landscape as investors await widespread vaccinations and lasting business reopenings. Weekly unemployment claims dipped below 900,000 for the first time in three weeks, albeit while remaining at a historically elevated level. And on Friday, new data showed that personal income rose more than expected in December, while consumer spending ticked down less than feared.

Story continues

I think what were looking at is, weve got pockets around the market that are decidedly showing signs of bubble-ness so to speak, whether that comes from what we saw [Wednesday], which was really a side-show of the markets, related to these shorted stocks that were driven up higher by individual investors, John Stoltzfus, Oppenheimer chief markets strategist, told Yahoo Finance on Thursday. The other side of it would be on a fundamental basis, what we are seeing is an economy that is positioning itself for a recovery process. And that means your core equities are likely to have an opportunity to move higher.

The valuation might be stretched in terms of a more conventional period, but right now with the Fed essentially magnanimously providing liquidity and fiscal policy coming to the rescue at least one more time to help small businesses and individuals, we would say that valuations are probably reflecting the current environment, and a need for investors who have intermediate to long term goals to invest in stories that are fundamentally sound, Stoltzfus added.

Pending home sales edged lower in December over November, steadying after a surge in housing market activity over the course of 2020.

Pending home sales declined 0.3% during the month, according to the National Association of Realtors (NAR) Pending Home Sales Index. This was better than the drop of 0.5% expected, according to Bloomberg consensus data.

Despite the month-over-month dip, pending home sales still remained 22.8% higher over the same month of 2019, as demand for new homes while social distancing as low mortgage rates buoyed housing market activity.

Here were the main moves in markets, as of 9:31 a.m. ET:

S&P 500 (^GSPC): -27.04 points (-0.71%) to 3,760.34

Dow (^DJI): -271.5 (+0.9%) to 30,331.86

Nasdaq (^IXIC): -42.88 (-39.33%) to 13,297.82

Crude (CL=F): +$0.71 (+1.36%) to $53.05 a barrel

Gold (GC=F):+$37.70 (+2.05%) to $1,878.90 per ounce

10-year Treasury (^TNX): +3.9 bps to yield 1.094%

U.S. personal income increased by 0.6% in December after a downwardly revised drop of 1.3% in November, the Bureau of Economic Analysis said Friday. Decembers increase was better than the 0.1% tick up consensus economists expected, according to Bloomberg data.

The increase to personal income mostly came as a result of increased government social benefits, compensation and personal dividend income, the BEA reported. This included benefits through the pandemic unemployment assistance programs, which were renewed until March.

Personal spending, the biggest component of U.S. economic activity, ticked down just 0.2% in December, or half the expected decline for the month. This followed a revised drop of 0.7% in November.

The personal saving rate, or savings as a percentage of disposable income, increased for the first time since April in December, ticking up to 13.7% from 12.9%. This remained well above the pre-pandemic average rate of below 7.5% throughout 2019.

Core personal consumption expenditures, the Federal Reserves core inflation gauge, increased by only 1.3% year-over-year in December, coming in well below the Feds 2% target yet again.

Johnson & Johnson (JNJ) reported Friday morning that its new single-shot COVID-19 vaccine was 66% effective in preventing moderate to severe cases of the virus 28 days after vaccination. The data was based on a global study including more than 44,000 participants. In the U.S. alone, the efficacy rate for the vaccine was 72%.

The vaccine also prevented 85% of severe infections and 100% of hospitalizations and deaths, the company added.

The efficacy data came in below that from Pfizer and Moderna, with these drugmakers shots each conferring well over 90% efficacy in preventing COVID-19. However, unlike Pfizers and Modernas vaccines, J&Js is delivered in just a single dose, and can be stored for longer periods of times at less extreme temperatures.

J&J said it plans to file for emergency use authorization in the U.S. in February and expects to have product immediately available for shipment at that time.

Scott Gottlieb, former U.S. Food and Drug Administration Commissioner, said in a Twitter post Friday morning that J&Js vaccine data was a fantastic result.

Heres where markets were trading on Friday ahead of the opening bell:

S&P 500 futures (ES=F): 3,756.75, down 22.5 points or 0.6%

Dow futures (YM=F): 30,358.00, down 149 points or 0.49%

Nasdaq futures (NQ=F): 13,074.00, down 112 points or 0.85%

Crude (CL=F): +$0.24 (+0.46%) to $52.58 a barrel

Gold (GC=F): +$1,868.30 (+1.47%) to $1,868.30 per ounce

10-year Treasury (^TNX): +1.6 bps to yield 1.071%

Here were the main moves in markets, as of 6:24 p.m. ET Wednesday

S&P 500 futures (ES=F): 3,770.25, down 9 points or 0.24%

Dow futures (YM=F): 30,474.00, down 33 points or 0.11%

Nasdaq futures (NQ=F): 13,171.75, down 14.25 points or 0.11%

Emily McCormick is a reporter for Yahoo Finance. Follow her on Twitter: @emily_mcck

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, and reddit.

Find live stock market quotes and the latest business and finance news

For tutorials and information on investing and trading stocks, check out Cashay

See the original post here:

Stock market news live updates: Stocks fall, looking to end the week lower - Yahoo Finance

ATLANTA The Brooklyn Nets were a few seconds away from staving off a young Atlanta Hawks squad on the road inside of State Farm Arena on Wednesday night.

With four seconds remaining in overtime, James Harden was at the charity stripe and Hawks star point guard Trae Young was positioned behind him staring into space in deep thought. He looked as if he was itching for a couple of do-overs.

The rising Hawks had fought valiantly throughout and led for much of the contest. They had their chances to win. In the end, the three-headed superstar trio of Harden, Kevin Durant and Kyrie Irving were too much to overcome down the stretch, accounting for 89 of the teams 132 points in a four-point Nets win.

Young finished the evening with 28 points and 14 assists. The third-year guard issued Yahoo Sports an exclusive phone interview to discuss what he was thinking late in the game, the misperception of the Hawks locker room and a look into the latest phase of the franchises developmental chapter.

When the game got to that point [with Harden at the line sealing the victory], I was just thinking that Im looking forward to the next matchup against them, Young told Yahoo Sports. I think for us, being in the East and having a chance to possibly see them in the playoffs and maybe see them in the second half of the season, I just love playing against the best. Thats always fun. So when you get a chance to play against them, it brings the best out of you. So when that happened at the end of the game, thats what I was thinking about, the next time we play them.

Prior to Wednesdays affair, the season series was tied at 1-1 with Atlanta winning the last game in Brooklyn by 18 points.

In the previous two seasons, the Hawks more than likely wouldnt have been able to compete for 48 minutes against a team of this caliber. Now, Clint Capela who is making a case for All-Star consideration is racking up massive double-double numbers while protecting the paint and Hawks coach Lloyd Pierce is equipped with a nucleus of John Collins, DeAndre Hunter and Cam Reddish who are showing immense promise as long, versatile defenders capable of switching everything.

Story continues

The Hawks are trending upwards.

I read a stat a couple days ago that we didnt win our seventh game last year until our 35th game, and were 9-9 right now, Young told Yahoo Sports. So for us, were winning and were getting better. Thats my main focus and if were doing that, everything else will take care of itself.

But with success, often comes scrutiny.

The Athletic reported earlier in the month about a film session in which Collins reportedly criticized Young for mismanaging the clock on the offensive end and questioned his early shot-clock heaves. The leadership skills of the 22-year-old franchise player were suddenly in question.

On a young team, those sort of gripes are routine across the league. But Young insists the episode was overblown.

Of course if theres anything out there publicly, I always go directly to [that person], Young relayed to Yahoo Sports. As for the John [Collins] incident, me and him talked about it as soon as it got out the next day and we were both confused. It just got out and it was over a regular film session. So theres no beef or anything in there to begin with. There hasnt been any locker room issues on my side. Anything that people were saying about locker room issues, there hasnt been one. Its all about our team and how weve been trying to get better in film sessions.

Another area of scrutiny Young has endured as of late is his foul-drawing ability. He has a knack for using a screen to get around his defender, sealing him on his backside and causing the opponent to run into him.

Nets coach Steve Nash and New York Knicks coach Tom Thibodeau, along with multiple players, have complained to the officials about Youngs tactic for getting to the line.

Ive obviously seen it. Ive seen a lot more talking about fouls this year and me just being able to draw fouls and the way Im drawing them, Young told Yahoo Sports. If you look at my track history going back to high school, I averaged 42 points and Im pretty sure I shot 17 free throws a game. And in college, I led the country in free throws my freshman year. Ive always been able to know how to get to the free-throw line. Its little things like that people are pointing out this year, but its stuff Ive been doing my whole life.

Young said hes built for whatever may come his way. And that bodes well for the Hawks whose mission is to return to a place they haven't been in five years.

Making the playoffs is the main goal for us, Young told Yahoo Sports so adamantly. For us, these past couple of years, its been more of a development stage. Were all pretty young and of course were trying to win each and every night, but everybodys main focus was to get better each and every day. And when youre hearing that all the time, thats really the main focus. So now, its like, How can we win each and every day. Its a different mindset around here now.

More from Yahoo Sports:

Read the original post:

Trae Young-led Hawks holding own against league's best as they focus on making the playoffs - Yahoo Sports

The pandemic, stimulus checks, the ability to own less than one full stock, and concurrent rise of commission-free trading have coalesced into ripe conditions for first-time investors. Its been a good time for both buy-and-hold types and the daytraders meme-ing Gamestop (GME) to the moon. (The stock has soared more than 1,000% so far in January, though check because its changing every minute..)

Robinhood, which is responsible for popularizing both commission-free trades and fractional investing, has long had the goal of democratizing investing. In an interview with Yahoo Finance, CEO Vlad Tenev explained that the investing climate of the past few days has illustrated a key problem in the world of investing inequity.

Retail investors and individuals have felt like theyve been talked down to. Lots of them felt like they havent been taken seriously, he said. Theres this term 'sophisticated investor thats been thrown around, so theres an idea that theyre unsophisticated.

Over the past few days, a group of retail investors on Reddit have swarmed on a few stocks, many with short positions held by hedge funds the establishment. Because these stocks are relatively small in terms of market capitalization, the retail investors have been winning.

There's a lot of pent-up aggravation at the financial services industry that's been brewing for the last 13 years, one Redditor told Yahoo Finance on Wednesday. .

[Read more: GameStop phenomena is about 'the poor vs rich': Reddit WSB user]

As one former hedge funder wisely said, its easier to fight 100 mini Mike Tysons than a big one, and thats what the upstarts are doing.

I think people are seeing now that [retail investors] now have the ability to invest and theyre empowered, Tenev said.

Clearly, the sophistication required to both have a solid investing thesis but also convince others of that thesis, resulting in margin calls for the short sellers, is something new and impressive.

Story continues

One theme going around since the beginning of this latest retail investing boom is that this group is getting smarter. New investors, eager to learn, are driving up traffic to brokerages websites with educational content. Perhaps with GameStop the retail investors the day-trading side are having their Terminator Skynet moment, becoming sentient and gaining the upper hand, at least in certain cases.

Tenev told Yahoo Finance that Robinhood had over 3.2 million people visit their education resource pages last year. (Robinhood has around 13 million accounts.)

Just this past week we updated [the education pages] and launched a revamped version of our portal, which makes it really easy to go from the basic concepts of investing all the way through the more advanced concepts involving options trading, Tenev said.

Daytrading may be more exciting, but its not the bread and butter of the platform, Tenev was quick to add.

The truth is, while the activity around more active investing is probably more interesting to report on, the bulk of customers in Robinhood engage in whats typically called buy and hold behavior, Tenev said. The majority of Robinhood customers are what they call 401(k) savers, long-term investors.

Options trading, on the other hand, is a small fraction of the users were seeing, Tenev said.

---

Ethan Wolff-Mann is a writer at Yahoo Finance focusing on consumer issues, personal finance, retail, airlines, and more. Follow him on Twitter @ewolffmann.

Here is the original post:

Robinhood CEO: The retail investors that have felt 'talked down to' are now 'empowered' - Yahoo Finance

By Julie Steenhuysen

Jan 29 (Reuters) - Johnson & Johnson on Friday said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States but a lower rate of 66% was observed globally in the large trial conducted across three continents and against multiple variants.

In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 was 66% in Latin America and just 57% in South Africa, where a particularly worrying variant of the novel coronavirus is circulating.

Those results compare to the high bar set by two authorized vaccines from Pfizer Inc/BioNTech SE and Moderna Inc, which were around 95% effective in preventing symptomatic illness in pivotal trials when given in two doses. Those trials, however, were conducted mainly in the United States and before the broad spread of new variants now under the spotlight.

J&J's main study goal was the prevention of moderate to severe COVID-19, and the vaccine was 85% effective in stopping severe disease and preventing hospitalization across all geographies and against multiple variants 28 days after immunization.

That level of prevention "will potentially protect hundreds of millions of people from serious and fatal outcomes of COVID-19," Dr. Paul Stoffels, J&J's chief scientific officer, said in a statement.

The company plans to seek emergency use authorization from the U.S. Food and Drug Administration next week.

Public health officials have been counting on the J&J vaccine to increase much-needed supply and simplify the U.S. immunization campaign.

Unlike the Pfizer/BioNTech and Moderna vaccines, J&J's does not require a second shot weeks after the first or need to be kept frozen, making it a strong candidate for use in parts of the world with weak transportation infrastructure and insufficient cold storage facilities.

SOUTH AFRICA

Several studies have emerged this month showing that a South African variant of the coronavirus has mutated in areas of the virus that are key targets of vaccines, reducing their efficacy.

Story continues

"What we are learning is there is different efficacy in different parts of the world," Stoffels said in a telephone interview.

Importantly, though, in a sub-study of 6,000 volunteers in South Africa, Stoffels said, the J&J vaccine was 89% effective at preventing severe disease. Ninety-five percent of cases in the South Africa portion of the trial were infections with the South African variant.

A mid-stage trial of a Novovax Inc coronavirus vaccine in South Africa also showed lower efficacy in the country. It proved to be 60% effective among volunteers who didn't have HIV. In a separate, late-stage trial in the UK, the vaccine was 89.3% effective.

In the J&J trial, which was conducted in eight countries, 44% of participants were from the United States, 41% were from Central and South America and 15% were from South Africa. Slightly more than a third of the volunteers were over age 60.

There were no serious adverse events among those who received the shot, the company said. Full results will be published in a peer-reviewed journal.

J&J's vaccine uses a common cold virus known as adenovirus type 26 to introduce coronavirus proteins into cells in the body and trigger an immune response.

The Pfizer/BioNTech and Moderna vaccines use a new technology called messenger RNA (mRNA) that requires it to be stored in a freezer.

VACCINE TARGETS

The news of another safe and effective vaccine comes as the United States has surpassed 430,000 COVID-19 deaths and with hospitals in many states still struggling to keep up with patients despite recent declines in new infections.

Concerns about fresh surges in the United States have also grown due to the presence of a more contagious coronavirus variant first discovered in the UK and news of the arrival of the South African variant on Thursday in South Carolina.

The U.S. vaccination program got off to a slow start in December and has accelerated to around 1 million shots per day nationwide.

U.S. President Joe Biden has promised that at least 100 million shots will be administered in his first 100 days in office, but concerns about supply disruptions have added uncertainty to that target.

The United States has an agreement to buy 100 million doses of J&J's vaccine for $1 billion. The company said in a statement the vaccine would be ready immediately upon emergency approval but Stoffels declined to specify how many doses. The government also has the option of purchasing an additional 200 million doses.

J&J has said it plans to deliver 1 billion doses in 2021 and will produce the vaccine in the United States, Europe, South Africa and India.

U.S. trial results for the vaccine from AstraZeneca Plc and Oxford University are expected in early February, opening up the possibility of a fourth vaccine option. It has already been approved in the UK, Europe and many countries based on results of a separate trial.

Novavax is also discussing with the FDA whether its data is sufficient to apply for emergency use authorization.

J&J is studying the effects of its vaccine given in two doses at two months apart, but results of that trial won't be available until this summer, Stoffels said.

(Reporting by Julie Steenhuysen; additional reporting by Manas Mishra and Dania Nadeem in Bangalore; editing by Caroline Humer, Peter Henderson and Edwina Gibbs)

Originally posted here:

J&J COVID-19 vaccine is 72% effective in the U.S., and 66% overall in large trial - Yahoo Finance